Newsfeeds - Spark Newswire

1 minute read

Agilent Raises FY22 Adj. EPS Guidance From $4.76-$4.86 To $4.86-$4.93 vs $4.60 Estimate, Sales From $6.65B-$6.73B To $6.67B-$6.73B vs $6.36B Est.

May 24, 4:08 PM

Agilent Sees Q1 Adj. EPS $1.16-$1.18 vs $1.02 Et., Sales $1.64B-$1.66B vs $1.47B Est.; Sees FY22 Adj. EPS $4.76-$4.86 vs $4.24 Est., Sales $6.65B-$6.73B vs $6.01B Est.

1 minute read

Agilent Technologies Q2 EPS $1.13 Beats $1.07 Estimate, Sales $1.61B Beat $1.55B Estimate

By Michael Horton

May 24, 4:07 PM

Agilent Technologies (NYSE:A) reported quarterly earnings of $1.13 per share which beat the analyst consensus estimate of $1.07 by 5.61 percent. This is a 16.49 percent increase over earnings of $0.97 per share from the

3 minute read

Earnings Scheduled For May 24, 2022

By Benzinga Insights

May 24, 4:35 AM

Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is estimated to report quarterly earnings at $1.89 per share on revenue of $1.26 billion.

2 minute read

Agilent Reports Its pharmDX, Code SK006 Now European Union CE In Vitro Device-Marked For Use In Cervical Cancer

By Benzinga Newsdesk

May 10, 3:55 PM

Agilent Technologies Inc. (NYSE:A) today announced that its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying

1 minute read

If You Invested $1000 In Agilent Technologies 15 Years Ago, Here’s How Much You Would Have Today

By Benzinga Insights

April 28, 2:32 PM

Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.03% on an annualized basis producing an average annual return of 8.21%. Currently, Agilent Technologies has a market capitalization of $36.29 billion.

33 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

April 26, 1:44 PM

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

1 minute read

FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis

By Vandana Singh

April 20, 3:44 PM

The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a…

2 minute read

Analyzing Agilent Technologies Inc’s Short Interest

By Benzinga Insights

April 1, 12:02 PM

Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 9.2% since its last report. The company recently reported that it has 4.42 million shares sold short, which is 1.48% of all regular shares that are available for trading.

1 minute read

Here’s How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years

By Benzinga Insights

March 1, 2:01 PM

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.57% on an annualized basis.

2 minute read

Looking Into Agilent Technologies Inc’s Recent Short Interest

By Benzinga Insights

February 25, 5:07 PM

Agilent Technologies Inc's (NYSE:A) short percent of float has risen 7.36% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 1.75% of all regular shares that are available for trading.